BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37934378)

  • 1. Imaging in Type 1 Diabetes, Current Perspectives and Directions.
    Tinklepaugh J; Mamrak NE
    Mol Imaging Biol; 2023 Dec; 25(6):1142-1149. PubMed ID: 37934378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in molecular imaging of pancreatic beta cells.
    Lin M; Lubag A; McGuire MJ; Seliounine SY; Tsyganov EN; Antich PP; Sherry AD; Brown KC; Sun X
    Front Biosci; 2008 May; 13():4558-75. PubMed ID: 18508529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiological Advances in Pancreatic Islet Transplantation.
    Cahill D; Zamboni F; Collins MN
    Acad Radiol; 2019 Nov; 26(11):1536-1543. PubMed ID: 30709732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Life and death of β cells in Type 1 diabetes: A comprehensive review.
    Wilcox NS; Rui J; Hebrok M; Herold KC
    J Autoimmun; 2016 Jul; 71():51-8. PubMed ID: 27017348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell Therapy for Type 1 Diabetes: Current and Future Strategies.
    Aghazadeh Y; Nostro MC
    Curr Diab Rep; 2017 Jun; 17(6):37. PubMed ID: 28432571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Hormone-Negative Endocrine Cells in the Pancreas in Type 1 Diabetes.
    Md Moin AS; Dhawan S; Shieh C; Butler PC; Cory M; Butler AE
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3487-96. PubMed ID: 27300574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 1 diabetes mellitus: much progress, many opportunities.
    Powers AC
    J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33759815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased VMAT2 in the pancreas of humans with type 2 diabetes mellitus measured in vivo by PET imaging.
    Cline GW; Naganawa M; Chen L; Chidsey K; Carvajal-Gonzalez S; Pawlak S; Rossulek M; Zhang Y; Bini J; McCarthy TJ; Carson RE; Calle RA
    Diabetologia; 2018 Dec; 61(12):2598-2607. PubMed ID: 29721633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From immunohistological to anatomical alterations of human pancreas in type 1 diabetes: New concepts on the stage.
    Nigi L; Maccora C; Dotta F; Sebastiani G
    Diabetes Metab Res Rev; 2020 May; 36(4):e3264. PubMed ID: 31850667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Map of Human Type 1 Diabetes Progression by Imaging Mass Cytometry.
    Damond N; Engler S; Zanotelli VRT; Schapiro D; Wasserfall CH; Kusmartseva I; Nick HS; Thorel F; Herrera PL; Atkinson MA; Bodenmiller B
    Cell Metab; 2019 Mar; 29(3):755-768.e5. PubMed ID: 30713109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges with Cell-based Therapies for Type 1 Diabetes Mellitus.
    Siwakoti P; Rennie C; Huang Y; Li JJ; Tuch BE; McClements L; Xu X
    Stem Cell Rev Rep; 2023 Apr; 19(3):601-624. PubMed ID: 36434300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Assessment of
    Espes D; Carlsson PO; Selvaraju RK; Rosestedt M; Cheung P; Ahlström H; Korsgren O; Eriksson O
    Diabetes; 2021 Apr; 70(4):966-975. PubMed ID: 33479059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Cell differentiation and regeneration in type 1 diabetes.
    Ding L; Gysemans C; Mathieu C
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():98-104. PubMed ID: 24003926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time imaging of the pancreas during development of diabetes.
    Martinic MM; von Herrath MG
    Immunol Rev; 2008 Feb; 221():200-13. PubMed ID: 18275484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent trends and advances in type 1 diabetes therapeutics: A comprehensive review.
    Singh A; Afshan N; Singh A; Singh SK; Yadav S; Kumar M; Sarma DK; Verma V
    Eur J Cell Biol; 2023 Jun; 102(2):151329. PubMed ID: 37295265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreas tissue slices from organ donors enable in situ analysis of type 1 diabetes pathogenesis.
    Panzer JK; Hiller H; Cohrs CM; Almaça J; Enos SJ; Beery M; Cechin S; Drotar DM; Weitz JR; Santini J; Huber MK; Muhammad Fahd Qadir M; Pastori RL; Domínguez-Bendala J; Phelps EA; Atkinson MA; Pugliese A; Caicedo A; Kusmartseva I; Speier S
    JCI Insight; 2020 Apr; 5(8):. PubMed ID: 32324170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Futility of attempts to detect and quantify beta cells by PET imaging in the pancreas: why it is time to abandon the approach.
    Alavi A; Werner TJ
    Diabetologia; 2018 Dec; 61(12):2512-2515. PubMed ID: 29955934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET/MRI enables simultaneous
    Michelotti FC; Bowden G; Küppers A; Joosten L; Maczewsky J; Nischwitz V; Drews G; Maurer A; Gotthardt M; Schmid AM; Pichler BJ
    Theranostics; 2020; 10(1):398-410. PubMed ID: 31903128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The beta-cell in type 1 diabetes: What have we learned from proteomic studies?
    Crèvecoeur I; Rondas D; Mathieu C; Overbergh L
    Proteomics Clin Appl; 2015 Aug; 9(7-8):755-66. PubMed ID: 25641783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of proteomics in assessing beta-cell dysfunction and death in type 1 diabetes.
    Nakayasu ES; Qian WJ; Evans-Molina C; Mirmira RG; Eizirik DL; Metz TO
    Expert Rev Proteomics; 2019 Jul; 16(7):569-582. PubMed ID: 31232620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.